Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial.
Pastor-Pérez FJ, Garrido-Bravo IP, Peñafiel-Verdú P, Fernández-Villa N, Manzano-Fernández S, Oliva-Sandoval MJ, Pérez-Martínez MT, Caro-Martínez C, Hernández-Vicente Á, Pascual-Figal DA; clinical trial REMOVE researches. Pastor-Pérez FJ, et al. Among authors: caro martinez c. Rev Esp Cardiol (Engl Ed). 2024 Oct;77(10):851-858. doi: 10.1016/j.rec.2024.02.021. Epub 2024 May 1. Rev Esp Cardiol (Engl Ed). 2024. PMID: 38701881 Clinical Trial. English, Spanish.
Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study.
Pascual-Figal DA, Zamorano JL, Domingo M, Morillas H, Nuñez J, Cobo Marcos M, Riquelme-Pérez A, Teis A, Santas E, Caro-Martinez C, Pinilla JM, Rodriguez-Palomares JF, Dobarro D, Restrepo-Córdoba MA, González-Juanatey JR, Bayés Genís A; DAPA-MODA Study Investigators. Pascual-Figal DA, et al. Among authors: caro martinez c. Eur J Heart Fail. 2023 Aug;25(8):1352-1360. doi: 10.1002/ejhf.2884. Epub 2023 Jun 7. Eur J Heart Fail. 2023. PMID: 37211950 Free article.
Aortic valve stenosis provides complementary information to bleeding risk scores in non-valvular atrial fibrillation patients initiating anticoagulation.
Elvira-Ruiz G, Caro-Martínez C, Flores-Blanco PJ, Cerezo-Manchado JJ, Albendín-Iglesias H, Lova-Navarro A, Arregui-Montoya F, Muñoz-Franco FM, García-Iniesta N, García-Alberola A, Bailén-Lorenzo JL, Pascual-Figal DA, Manzano-Fernández S. Elvira-Ruiz G, et al. Among authors: caro martinez c. J Geriatr Cardiol. 2020 Mar;17(3):141-148. doi: 10.11909/j.issn.1671-5411.2020.03.005. J Geriatr Cardiol. 2020. PMID: 32280330 Free PMC article.
Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non-vitamin K antagonists.
Elvira Ruiz G, Caro Martínez C, Flores Blanco PJ, Cerezo Manchado JJ, Albendín Iglesias H, Lova Navarro A, Arregui Montoya F, García Alberola A, Pascual Figal DA, Bailén Lorenzo JL, Manzano-Fernández S. Elvira Ruiz G, et al. Among authors: caro martinez c. Eur J Clin Invest. 2019 Oct;49(10):e13161. doi: 10.1111/eci.13161. Epub 2019 Aug 26. Eur J Clin Invest. 2019. PMID: 31449685
Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry.
Navarro-Almenzar B, Cerezo-Manchado JJ, Caro-Martinez C, García-Candel F, Flores Blanco PJ, Ruiz GE, Andreu Cayuelas JM, Montoya FA, Cascales A, Lova Navarro A, García Alberola A, Andrés Pascual Figal D, Bailen Lorenzo JL, Manzano-Fernández S. Navarro-Almenzar B, et al. Among authors: caro martinez c. Curr Med Res Opin. 2019 Dec;35(12):2035-2041. doi: 10.1080/03007995.2019.1647735. Epub 2019 Sep 11. Curr Med Res Opin. 2019. PMID: 31335222
Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry.
Caro Martinez C, Cerezo Manchado JJ, Flores Blanco PJ, Elvira Ruíz G, Albendín Iglesias H, Lova Navarro A, Arregui Montoya F, García Alberola A, Andrés Pascual Figal D, Bailén Lorenzo JL, Navarro-Almenzar B, García-Candel F, Manzano Fernández S. Caro Martinez C, et al. Curr Med Res Opin. 2019 Aug;35(8):1463-1471. doi: 10.1080/03007995.2019.1600483. Epub 2019 Apr 15. Curr Med Res Opin. 2019. PMID: 30912682
Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants.
Caro Martínez C, Elvira Ruiz G, Flores Blanco PJ, Cerezo Manchado JJ, Albendín Iglesias H, Lova Navarro A, Arregui Montoya F, García Alberola A, Pascual Figal DA, Bailén Lorenzo JL, Manzano Fernández S. Caro Martínez C, et al. Rev Esp Cardiol (Engl Ed). 2019 Nov;72(11):935-943. doi: 10.1016/j.rec.2018.08.026. Epub 2018 Nov 27. Rev Esp Cardiol (Engl Ed). 2019. PMID: 30497945 English, Spanish.
Effectiveness and safety of rivaroxaban in a cohort of 142 patients with nonvalvular atrial fibrillation treated with rivaroxaban for the prevention of stroke.
Cerezo-Manchado JJ, Navarro-Almenzar B, Elvira-Ruiz G, García-Candel F, Flores-Blanco PJ, Caro-Martínez C, Manzano-Fernández S, García-Iniesta N, Sánchez-García J, Cabañas-Perianes V, Moraleda-Jiménez JM. Cerezo-Manchado JJ, et al. Among authors: caro martinez c. Future Cardiol. 2018 May;14(3s):31-37. doi: 10.2217/fca-2018-0024. Future Cardiol. 2018. PMID: 29848091
Kidney function monitoring and nonvitamin K oral anticoagulant dosage in atrial fibrillation.
Andreu Cayuelas JM, Caro Martínez C, Flores Blanco PJ, Elvira Ruiz G, Albendin Iglesias H, Cerezo Manchado JJ, Bailen Lorenzo JL, Januzzi JL, García Alberola A, Manzano-Fernández S. Andreu Cayuelas JM, et al. Among authors: caro martinez c. Eur J Clin Invest. 2018 Jun;48(6):e12907. doi: 10.1111/eci.12907. Epub 2018 Apr 22. Eur J Clin Invest. 2018. PMID: 29423910
18 results